Government,
Intellectual Property
Oct. 10, 2017
Legislation introduced to block Allergan’s patent deal with tribe
A U.S. senator has introduced legislation to block a pharmaceutical company’s novel bid to transfer patents for its eye medication to a Native American tribe.
A U.S. senator has introduced legislation to block a pharmaceutical company’s novel bid to transfer patents for its eye medication to a Native American tribe.
The bill is aimed at stopping Allergan PLC’s deal with the St. Regis Mohawk Tribe in New York, which is pursuing a motion to dismiss an ongoing review by the U.S. Patent and Trademark Office of the patents, citing the tribe’s sovereign immunity.
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In